Přejít k obsahu
Merck

An investigation of the antiplatelet effects of succinobucol (AGI-1067).

Platelets (2016-09-30)
Stephanie A Houston, Azizah Ugusman, Sukanya Gnanadesikan, Simon Kennedy
ANOTACE

Succinobucol is a phenolic antioxidant with anti-inflammatory and antiplatelet effects. Given the importance of oxidant stress in modulating platelet-platelet and platelet-vessel wall interactions, the aim of this study was to establish if antioxidant activity was responsible for the antiplatelet activity of succinobucol. Platelet aggregation in response to collagen and adenosine diphosphate (ADP) was studied in rabbit whole blood and platelet-rich plasma using impedance aggregometry. The effect of oxidant stress on aggregation, platelet lipid peroxides, and vascular tone was studied by incubating platelets, washed platelets or preconstricted rabbit iliac artery rings respectively with a combination of xanthine and xanthine oxidase (X/XO). To study the effect of succinobucol in vivo, anaesthetized rats were injected with up to 150 mg/kg succinobucol and aggregation measured in blood removed 15 mins later. Succinobucol (10

MATERIÁLY
Číslo produktu
Značka
Popis produktu

Sigma-Aldrich
Succinobucol, ≥98% (HPLC)